Squarepoint’s Alzamend Neuro ALZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-15
Closed -$24K 2848
2022
Q1
$24K Buy
+15
New +$28.2K ﹤0.01% 2709

Other funds holding ALZN

Squarepoint's ALZN Position: Q2 2022 in Review

Squarepoint sold out of Alzamend Neuro (ALZN) in Q2 2022, closing a stake of 15 shares — an estimated $24K sold.

Squarepoint first reported a position in ALZN in Q1 2022 and held it in 1 quarter. The position peaked at $24K in Q1 2022. 20 funds tracked by Wall St. Rank hold ALZN as of Q2 2022.

  • Squarepoint reported no remaining Alzamend Neuro position as of Q2 2022 after selling out during the quarter.
  • Squarepoint sold 15 Alzamend Neuro shares in Q2 2022, an estimated $24K.
  • Squarepoint first reported a position in Alzamend Neuro in Q1 2022 and held it in 1 quarter.
  • Squarepoint's Alzamend Neuro position peaked at $24K in Q1 2022.
  • 20 funds tracked by Wall St. Rank held Alzamend Neuro as of Q2 2022.

Based on Squarepoint's 13F filing for Q2 2022, filed 15 Aug 2022.